These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34587961)

  • 81. Second cancers after adjuvant tamoxifen therapy for breast cancer in Japan.
    Matsuyama Y; Tominaga T; Nomura Y; Koyama H; Kimura M; Sano M; Miura S; Takashima S; Mitsuyama S; Ueo H; Ohashi Y
    Ann Oncol; 2000 Dec; 11(12):1537-43. PubMed ID: 11205460
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Breast cancer in women using digoxin: tumor characteristics and relapse risk.
    Biggar RJ; Andersen EW; Kroman N; Wohlfahrt J; Melbye M
    Breast Cancer Res; 2013 Feb; 15(1):R13. PubMed ID: 23421975
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Statin use and breast cancer recurrence in postmenopausal women treated with adjuvant aromatase inhibitors: a Danish population-based cohort study.
    Harborg S; Heide-Jørgensen U; Ahern TP; Ewertz M; Cronin-Fenton D; Borgquist S
    Breast Cancer Res Treat; 2020 Aug; 183(1):153-160. PubMed ID: 32572715
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Sociodemographic factors and vestibular schwannoma: a Danish nationwide cohort study.
    Schüz J; Steding-Jessen M; Hansen S; Stangerup SE; Cayé-Thomasen P; Johansen C
    Neuro Oncol; 2010 Dec; 12(12):1291-9. PubMed ID: 21068153
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Socioeconomic position, type 2 diabetes and long-term risk of death.
    Dalsgaard EM; Skriver MV; Sandbaek A; Vestergaard M
    PLoS One; 2015; 10(5):e0124829. PubMed ID: 25942435
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Determinants of non-adherence to adjuvant endocrine treatment in women with breast cancer: the role of comorbidity.
    Wulaningsih W; Garmo H; Ahlgren J; Holmberg L; Folkvaljon Y; Wigertz A; Van Hemelrijck M; Lambe M
    Breast Cancer Res Treat; 2018 Nov; 172(1):167-177. PubMed ID: 30030708
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Social characteristics and social benefit use among premenopausal breast cancer survivors in Denmark: a population-based cohort study.
    Hjorth CF; Schmidt JA; Farkas DK; Cronin-Fenton D
    J Cancer Surviv; 2024 Apr; ():. PubMed ID: 38647591
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer.
    Francis PA; Pagani O; Fleming GF; Walley BA; Colleoni M; Láng I; Gómez HL; Tondini C; Ciruelos E; Burstein HJ; Bonnefoi HR; Bellet M; Martino S; Geyer CE; Goetz MP; Stearns V; Pinotti G; Puglisi F; Spazzapan S; Climent MA; Pavesi L; Ruhstaller T; Davidson NE; Coleman R; Debled M; Buchholz S; Ingle JN; Winer EP; Maibach R; Rabaglio-Poretti M; Ruepp B; Di Leo A; Coates AS; Gelber RD; Goldhirsch A; Regan MM;
    N Engl J Med; 2018 Jul; 379(2):122-137. PubMed ID: 29863451
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Long-term effectiveness of adjuvant goserelin in premenopausal women with early breast cancer.
    Hackshaw A; Baum M; Fornander T; Nordenskjold B; Nicolucci A; Monson K; Forsyth S; Reczko K; Johansson U; Fohlin H; Valentini M; Sainsbury R
    J Natl Cancer Inst; 2009 Mar; 101(5):341-9. PubMed ID: 19244174
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study.
    Klijn JG; Beex LV; Mauriac L; van Zijl JA; Veyret C; Wildiers J; Jassem J; Piccart M; Burghouts J; Becquart D; Seynaeve C; Mignolet F; Duchateau L
    J Natl Cancer Inst; 2000 Jun; 92(11):903-11. PubMed ID: 10841825
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Mammographic Density Decline, Tamoxifen Response, and Prognosis by Molecular Characteristics of Estrogen Receptor-Positive Breast Cancer.
    Abubakar M; Mullooly M; Nyante S; Pfeiffer RM; Aiello Bowles EJ; Cora R; Bodelon C; Butler E; Butcher D; Sternberg L; Troester MA; Weinmann S; Sherman M; Glass AG; Berrington de Gonzalez A; Gierach GL
    JNCI Cancer Spectr; 2022 May; 6(3):. PubMed ID: 35583138
    [TBL] [Abstract][Full Text] [Related]  

  • 92. HER2 status in hormone receptor positive premenopausal primary breast cancer adds prognostic, but not tamoxifen treatment predictive, information.
    Rydén L; Landberg G; Stål O; Nordenskjöld B; Fernö M; Bendahl PO
    Breast Cancer Res Treat; 2008 May; 109(2):351-7. PubMed ID: 17636399
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Adjuvant systemic therapy for women with node-negative breast cancer. The Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer.
    CMAJ; 1998 Feb; 158 Suppl 3():S43-51. PubMed ID: 9484278
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Menopausal symptoms among breast cancer patients: a potential indicator of favorable prognosis.
    Chen Y; Dorjgochoo T; Bao PP; Zheng Y; Cai H; Lu W; Shu XO
    PLoS One; 2013; 8(9):e75926. PubMed ID: 24098745
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Impact of menopausal status on risk of metastatic recurrence of breast cancer.
    Lao C; Elwood M; Kuper-Hommel M; Campbell I; Lawrenson R
    Menopause; 2021 Jul; 28(10):1085-1092. PubMed ID: 34260475
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Breast cancer incidence and case fatality among 4.7 million women in relation to social and ethnic background: a population-based cohort study.
    Beiki O; Hall P; Ekbom A; Moradi T
    Breast Cancer Res; 2012 Jan; 14(1):R5. PubMed ID: 22225950
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Socioeconomic status and its relation with breast cancer recurrence and survival in young women in the Netherlands.
    van Maaren MC; Rachet B; Sonke GS; Mauguen A; Rondeau V; Siesling S; Belot A
    Cancer Epidemiol; 2022 Apr; 77():102118. PubMed ID: 35131686
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Income Segregation, Conditional Cash Transfers, and Breast Cancer Mortality Among Women in Brazil.
    Guimarães JMN; Pescarini JM; Sousa Filho JF; Ferreira A; Almeida MDCC; Gabrielli L; Dos-Santos-Silva I; Santos G; Barreto ML; Aquino EML
    JAMA Netw Open; 2024 Jan; 7(1):e2353100. PubMed ID: 38270952
    [TBL] [Abstract][Full Text] [Related]  

  • 99. The long-term financial consequences of breast cancer: a Danish registry-based cohort study.
    Jensen LS; Overgaard C; Bøggild H; Garne JP; Lund T; Overvad K; Fonager K
    BMC Public Health; 2017 Oct; 17(1):853. PubMed ID: 29084512
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Socioeconomic position and the pre-diagnostic interval among patients diagnosed with head and neck squamous cell carcinoma - a population-based study from DAHANCA.
    Halgren Olsen M; Maltesen T; Lassen P; Kjaer TK; Johansen J; Primdahl H; Andersen E; Kristensen CA; Andersen M; Farhadi M; Overgaard J; Dalton SO
    Acta Oncol; 2023 Nov; 62(11):1394-1402. PubMed ID: 37672036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.